📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
iValue Infosolutions Outlines AI Growth Strategy and India AI Mission Opportunities
iValue Infosolutions held a business update call to discuss the transformative impact of AI on its service offerings in cybersecurity and IT infrastructure. The management highlighted the India AI Mission, which has already deployed over 38,000 GPUs and registered 2,300+ startups, as a major tailwind for the industry. With India generating 400 million terabytes of data daily, the company is positioning itself as a key integrator for enterprises in BFSI, Healthcare, and Retail. The strategy focuses on addressing AI complexities, including governance of 'Shadow AI' and sovereign compute requirements.
Key Highlights
India AI Mission has deployed 38,000+ GPUs with a dedicated budget to support over 2,300 registered startups.
India generates approximately 400 million terabytes of data daily, necessitating advanced AI-driven churn and analysis.
Identified BFSI as a high-impact sector where typical banks manage 700 to 800 applications generating vast data pools.
Focusing on 'Shadow AI' governance to help organizations protect private data from being uploaded to public Generative AI tools.
Positioning as an integrated solution provider for the 'Sovereign Compute' shift, ensuring data remains within Indian data centers.
💼 Action for Investors
Investors should view this as a positive strategic alignment with India's digital infrastructure goals, though execution in the competitive AI integration space remains key. Monitor future earnings for specific revenue contributions from AI-led infrastructure and security projects.
Fractal Q3 FY26 Revenue Grows 21% YoY to INR 8,544 Million; Quarterly PAT Crosses INR 1 Billion
Fractal Analytics reported a strong Q3 FY26 with revenue from operations reaching INR 8,544 million, a 21% YoY increase. The company achieved a significant milestone as quarterly Profit After Tax (PAT) crossed the INR 1 billion mark for the first time. Growth was primarily driven by the Healthcare and Life Sciences vertical, which surged 78% YoY, while the core CPG and Retail segment grew by 14%. The company maintained a robust Net Revenue Retention (NRR) of 114% and expanded its 'Must-Win Clients' base to 127.
Key Highlights
Revenue from operations grew 21% YoY to INR 8,544 million, with constant currency growth at 14%.
Healthcare and Life Sciences vertical delivered exceptional 78% YoY growth, while BFSI grew 26%.
Quarterly Profit After Tax (PAT) surpassed the INR 1 billion milestone with a gross margin of 47.2%.
Net Revenue Retention (NRR) remained strong at 114%, with 83% of revenue coming from 127 Must-Win Clients.
Secured preferred supplier status with two 'Magnificent Seven' clients and launched Vaidya 2.0 healthcare AI model.
💼 Action for Investors
Investors should focus on the company's successful diversification into Healthcare and its ability to maintain high margins while scaling. The crossing of the INR 1 billion PAT milestone and preferred status with global tech giants are strong indicators of long-term competitive advantage in the AI services space.
Whirlpool of India Completes 100% Acquisition of Elica India with 3.18% Stake Purchase
Whirlpool of India Limited has successfully completed the acquisition of an additional 3.18% stake in Elica PB Whirlpool Kitchen Appliances Private Limited. This transaction involved the purchase of 154,105 equity shares, following an initial intimation made in February 2026. With this final step, Elica India has now become a 100% wholly-owned subsidiary of Whirlpool of India. This consolidation is expected to streamline operations and strengthen Whirlpool's presence in the premium kitchen appliances segment.
Key Highlights
Acquired 154,105 additional equity shares in Elica PB Whirlpool Kitchen Appliances Private Limited
The additional stake represents 3.18% of the total issued and paid-up share capital
Whirlpool of India now holds 100% ownership of Elica India, making it a wholly-owned subsidiary
The acquisition was finalized on March 10, 2026, concluding the process initiated in February 2026
💼 Action for Investors
Investors should view this as a positive strategic move to consolidate a key business segment. Monitor the upcoming quarterly results to see how full ownership impacts consolidated margins and revenue growth.
Choice International to Acquire Remaining 50% Stake in Choice Insurance for ₹62.5 Crore
Choice International Limited has received IRDAI approval to acquire the remaining 50% equity stake in its subsidiary, Choice Insurance Broking India Private Limited. The company is purchasing 6,60,000 shares at ₹947 per share for a total cash consideration of ₹62.50 crore. Following this transaction, Choice Insurance will become a wholly-owned subsidiary of the company. The target entity has shown significant growth, with its turnover rising from ₹6.08 crore in FY23 to ₹88.59 crore in FY25.
Key Highlights
Acquisition of 6,60,000 equity shares at ₹947 per share, totaling ₹62.50 crore
Choice Insurance Broking becomes a 100% Wholly Owned Subsidiary post-acquisition
Target entity reported a turnover of ₹88.59 crore and net worth of ₹19.66 crore for FY25
Insurance broking revenue grew exponentially from ₹6.08 crore in FY23 to ₹88.59 crore in FY25
Necessary regulatory approval from IRDAI has been successfully obtained
💼 Action for Investors
This consolidation of a high-growth insurance vertical is a positive strategic move. Investors should monitor the impact on consolidated margins as the company gains full control over the subsidiary's cash flows.
Protean eGov Receives Tax Demand Order of ₹22.63 Crore Under MVAT and CST Acts
Protean eGov Technologies has received an Order-in-Appeal from the Deputy Commissioner of Sales Tax (Appeals), Mumbai, confirming a tax demand for the financial year 2015-16. The total demand amounts to approximately ₹22.63 crore, primarily related to the nature and scope of PAN services under the Maharashtra Value Added Tax (MVAT) Act. This follows a previous remand of the matter by the Maharashtra Sales Tax Tribunal in 2022. The company maintains that the demand is not maintainable and is evaluating legal options to file a further appeal.
Key Highlights
Total MVAT demand of ₹22,60,25,562 including interest of ₹4.94 crore and penalty of ₹3.53 crore
Additional CST demand of ₹3,20,096 including interest and penalties for the same period
The dispute pertains to PAN services rendered by the company during the 2015-16 period
Order-in-Appeal was issued against an original assessment order dated April 5, 2017
Company is exploring further legal appeals and does not envisage immediate material financial impact
💼 Action for Investors
Investors should monitor the outcome of the company's planned appeal as a final unfavorable ruling would result in a ₹22.6 crore liability. While the company is contesting the demand, this remains a contingent liability that could impact future cash flows.
IndiGo CEO Pieter Elbers Resigns; MD Rahul Bhatia Takes Interim Charge
InterGlobe Aviation (IndiGo) has announced the immediate resignation of its CEO, Pieter Elbers, effective March 10, 2026. Managing Director and founder Rahul Bhatia will assume interim management of the airline's affairs until a permanent successor is named. This leadership change occurs as IndiGo maintains a dominant market position with a fleet of 400+ aircraft and 124 million passengers served in CY25. The company expects to announce a new leader in short order to ensure continuity in its operational and strategic goals.
Key Highlights
CEO Pieter Elbers resigned effective close of business on March 10, 2026
Managing Director Rahul Bhatia to assume interim management responsibilities immediately
IndiGo currently operates a fleet of 400+ aircraft with over 2,200 daily flights
The airline served 124 million customers in CY25 across 135+ global destinations
Board expects to announce a new permanent leadership appointment in short order
💼 Action for Investors
Investors should monitor the timeline for a permanent CEO appointment and watch for any potential shifts in the airline's aggressive expansion strategy. While the founder's interim role provides stability, the sudden leadership transition may lead to short-term stock price volatility.
JSW Infrastructure Starts Interim Operations at Kudathini Rail Siding in Karnataka
JSW Infrastructure's wholly-owned subsidiary, JSW Port Logistics Private Limited, has officially commenced interim operations at its brownfield Rail Siding located in Kudathini, Ballari, Karnataka. This operational milestone follows the acquisition of the asset previously announced on September 11, 2025. The move is part of the company's strategy to enhance its last-mile connectivity and logistics capabilities. Investors should note that the transition from acquisition to operation is a key driver for future revenue growth in the logistics segment.
Key Highlights
Commencement of interim operations at the Kudathini Rail Siding in Ballari, Karnataka.
Asset managed by JSW Port Logistics Private Limited, a 100% subsidiary of JSW Infrastructure.
Follow-up to the brownfield acquisition announced on September 11, 2025.
Strategic expansion into rail-linked logistics to improve port-to-hinterland connectivity.
💼 Action for Investors
This is a positive development indicating efficient execution of post-acquisition integration. Investors should maintain a positive outlook as the company operationalizes its acquired assets to drive revenue growth.
Morepen Labs Secures ₹30 Crore Unsecured Working Capital Loan from KEB Hana Bank
Morepen Laboratories has entered into an agreement with KEB Hana Bank to avail an unsecured working capital term loan of ₹30 crore. The loan carries a competitive interest rate of 7.30% per annum (Repo + 2.05%) and has a tenure of 3 years, including a 6-month moratorium. This facility is backed by a personal guarantee from the Promoter and CMD, Mr. Sushil Suri. The company's existing debt, excluding this new facility, stands at ₹164.62 crore.
Key Highlights
Execution of a ₹30 crore unsecured working capital term loan facility with KEB Hana Bank.
Interest rate set at prevailing repo rate + 2.05%, currently effective at 7.30% per annum.
Loan tenure of 3 years with a 6-month moratorium and 5 half-yearly equal installments.
Personal guarantee provided by Promoter, Chairman & Managing Director Mr. Sushil Suri.
Total outstanding debt of the company (excluding this loan) is ₹164.62 crore as of March 10, 2026.
💼 Action for Investors
Investors should monitor the company's debt-to-equity ratio and ensure that the additional working capital effectively supports revenue growth. The promoter's personal guarantee is a positive sign of internal confidence in the company's repayment capacity.
Aster DM Appoints Founder Dr. Azad Moopen as Executive Director until May 2028
The Board of Aster DM Healthcare has approved the appointment of its founder, Dr. Azad Moopen, as an Executive Director effective from April 15, 2026, through May 28, 2028. This role is a redesignation from his current position as Managing Director, though he will continue to serve as the Chairman of the Company. The appointment is subject to shareholder approval via a postal ballot. This move is intended to ensure leadership continuity and leverage Dr. Moopen's decades of institutional knowledge and operational expertise.
Key Highlights
Dr. Azad Moopen appointed as Executive Director for a term from April 15, 2026, to May 28, 2028
Redesignated from Managing Director while retaining his position as Chairman of the Board
Appointment requires final approval from shareholders through a postal ballot process
Dr. Moopen has been associated with the company since its establishment in 1987
Leadership team includes family members Ms. Alisha Moopen (Deputy MD) and Dr. Zeba Azad Moopen (Non-Executive Director)
💼 Action for Investors
Investors should view this as a positive step for leadership stability and continuity of the company's strategic vision. No immediate action is required as the founder remains at the helm of the organization.
Central Bank of India Renews Co-Lending Tie-up with Capri Global Capital (AUM ₹23,916 Cr)
Central Bank of India has renewed its co-lending partnership with Capri Global Capital Ltd to offer secured Loan Against Property (LAP) and Gold Loans. Capri Global brings a substantial network of 1,331 branches across 19 states and an AUM of ₹23,916 crore as of December 2025. The partnership aims to leverage Capri's origination and servicing capabilities to expand the bank's credit portfolio at competitive rates. This arrangement complies with the revised RBI Co-Lending Arrangement guidelines issued in November 2025.
Key Highlights
Renewal of co-lending partnership with Capri Global Capital Ltd for Secured LAP and Gold Loans
Capri Global Capital manages a significant AUM of ₹23,916 crore as of December 31, 2025
Access to an extensive distribution network of 1,331 branches across 19 States and Union Territories
Adherence to revised RBI Co-Lending Arrangement (CLA) guidelines dated November 28, 2025
Joint credit processing and blended interest rates designed to enhance customer outreach and portfolio growth
💼 Action for Investors
Investors should monitor the growth in the bank's retail and MSME books through such partnerships, as they offer a low-cost expansion route. The focus on secured assets like Gold Loans and LAP is a positive sign for maintaining asset quality.
Waaree Renewable Bags Major 300 MWac/420 MWp Solar EPC Order
Waaree Renewable Technologies Limited (WAAREERTL) has signed a contract for the Engineering, Procurement, and Construction (EPC) of a 300 MWac / 420 MWp Ground Mount Solar PV Plant. The order was awarded by a domestic renewable energy power generation company and is scheduled for completion in FY 2027-28. This significant win bolsters the company's project pipeline and ensures medium-term revenue visibility. The contract is a commercial order with no promoter interest or related party involvement.
Key Highlights
Signed EPC contract for a 300 MWac (420 MWp) Ground Mount Solar PV Plant
Project execution is scheduled for completion during the financial year 2027-28
Awarded by a domestic entity specializing in renewable energy power generation
The contract is a commercial order and is not a related party transaction
💼 Action for Investors
Investors should view this as a positive development for the order book, providing revenue visibility through FY28. Monitor the company's execution efficiency and margin management as it scales its project portfolio.
CARE Places India Glycols on Rating Watch with Developing Implications Amid Demerger Plans
CARE Ratings has placed India Glycols' 'CARE A-' long-term rating on 'Rating Watch with Developing Implications' due to the proposed demerger of its Biofuel, Potable Spirits, and Bio-pharma businesses. The company's financial profile is improving, supported by a ₹467 crore preferential issue in Q3FY26 which was primarily used for debt reduction. Performance for 9MFY26 shows 11% revenue growth to ₹3,239 crore with margins expanding to 15.04%. The restructuring is expected to be completed within six months, resulting in three separate entities to enhance management focus.
Key Highlights
CARE A- rating placed on 'Rating Watch with Developing Implications' following the board-approved composite scheme of arrangement.
Raised ₹467 crore via preferential issue in Q3FY26, reducing total debt including LC acceptances to ₹1,793 crore as of January 2026.
9MFY26 revenue grew 11% YoY to ₹3,239 crore with PBILDT margins expanding significantly to 15.04%.
Net debt to PBILDT ratio is projected to improve to 2.5x-3.0x by FY26-end from 4.31x in FY25.
Demerger will split operations into IGL (Chemicals), IGL Spirits (Biofuels/Spirits), and Ennature Bio Pharma (Nutraceuticals).
💼 Action for Investors
Investors should maintain a watch on the NCLT approval process for the demerger, which is expected to unlock value across different business segments. The substantial debt reduction and improving margins provide a positive cushion during this transition period.
Aster DM Healthcare Holds Creditors Meeting for Merger with Quality Care India
Aster DM Healthcare convened a meeting of its unsecured trade creditors on March 10, 2026, to seek approval for the Scheme of Amalgamation with Quality Care India Limited. The meeting was held via video conferencing as directed by the NCLT Hyderabad bench, with 51 creditors in attendance. Remote e-voting was conducted between March 6 and March 9, 2026, to facilitate the approval process. The company is now awaiting the final scrutinizer's report to disclose the voting results to the exchanges.
Key Highlights
Meeting of unsecured trade creditors held on March 10, 2026, regarding the merger with Quality Care India Limited.
A total of 51 unsecured trade creditors participated in the NCLT-convened proceedings.
Remote e-voting was active from March 6, 2026 (9:00 AM) to March 9, 2026 (5:00 PM).
The amalgamation scheme is part of a strategic consolidation between the Transferor and Transferee companies.
💼 Action for Investors
Investors should watch for the official voting results to confirm creditor approval, which is a critical milestone for the merger. Successful amalgamation is expected to bring operational synergies and scale to Aster DM's healthcare portfolio.
Aster DM Shareholders Meet to Approve Merger with Quality Care India Limited
Aster DM Healthcare held an NCLT-convened meeting on March 10, 2026, to seek shareholder approval for the amalgamation of Quality Care India Limited into the company. The meeting was attended by 64 members via video conferencing and was chaired by an NCLT-appointed advocate. Management addressed shareholder queries regarding the rationale and salient features of the proposed scheme. The final voting results, including remote e-voting conducted between March 6-9, 2026, will be disclosed within the prescribed regulatory timelines.
Key Highlights
NCLT-convened meeting held on March 10, 2026, to approve the Scheme of Amalgamation with Quality Care India Limited.
Remote e-voting period concluded on March 9, 2026, at 5:00 P.M. IST prior to the general meeting.
A total of 64 members participated in the meeting through Video Conferencing and Other Audio Visual Means.
The scheme involves Quality Care India Limited as the Transferor Company and Aster DM Healthcare as the Transferee Company.
Final voting results and the Scrutinizer's report are expected to be disseminated to BSE and NSE shortly.
💼 Action for Investors
Investors should watch for the official voting results to confirm shareholder approval of the merger. Successful amalgamation is expected to consolidate operations and potentially enhance long-term value.
Excelsoft Appoints Retired IAS Officer Dr. J. Karuppusamy as Independent Director for 5 Years
Excelsoft Technologies has appointed Dr. Jayakumar Karuppusamy, a retired 1987-batch IAS officer and IIT/IIM alumnus, as an Independent Director for a five-year term effective March 10, 2026. Dr. Karuppusamy brings over two decades of experience in governance, technology, and administration, having served as Additional Chief Secretary and MD of State Bank of Sikkim. Alongside this appointment, the company has reconstituted its Audit and Nomination & Remuneration Committees, appointing Mr. Shivkumar Pundaleeka Divate as the new Audit Committee Chairperson. These leadership changes are aimed at strengthening the company's corporate governance and strategic oversight.
Key Highlights
Dr. Jayakumar Karuppusamy appointed as Independent Director for a 5-year term ending March 9, 2031
Appointee is a highly qualified professional with a PhD from IIT Kharagpur and a PGDM from IIM Bangalore
Mr. Shivkumar Pundaleeka Divate replaces Mr. Doreswamy Palaniswamy as Chairperson of the Audit Committee
Dr. Karuppusamy holds 4 Indian and 4 international patents and was recognized as an 'Amazing Indian' in 2023
The board meeting concluded in 41 minutes to approve these structural governance changes
💼 Action for Investors
Investors should view the addition of a high-profile former bureaucrat with technical and administrative expertise as a positive move for corporate governance. No immediate action is required, but this strengthens the board's oversight capabilities.
Waaree Energies Subsidiary to Invest $30 Million in United Solar Holdings Inc.
Waaree Energies' wholly owned subsidiary, Waaree Solar Americas Inc., has signed a Share Subscription Agreement to invest approximately $30 million in United Solar Holdings Inc. (USH). The deal involves the acquisition of 5,368,551 Series B preferred shares of USH, marking a significant strategic move in the American market. This transaction follows a preliminary disclosure made in December 2025 and is subject to standard closing conditions. The investment is an arm's length transaction with no related party involvement.
Key Highlights
Investment of approximately USD $30 million in United Solar Holdings Inc.
Subscription of 5,368,551 Series B preferred shares through US subsidiary Waaree Solar Americas Inc.
Strategic follow-up to the company's previous disclosure dated December 19, 2025.
Transaction is not a related party deal and involves no promoter interest.
💼 Action for Investors
Investors should view this as a positive step toward deepening the company's footprint in the US solar sector. Monitor for further updates on the closing of the transaction and potential operational synergies.
Hindustan Zinc Partners with CMR Green Technologies for Zinc Alloy Manufacturing at Zinc Park
Hindustan Zinc (HINDZINC) has signed a Memorandum of Understanding (MoU) with CMR Green Technologies to establish a zinc alloy manufacturing facility at Zinc Park in Rajasthan. This partnership, the second major one for the park, focuses on producing low-emission alloys for the automotive and infrastructure sectors. The initiative leverages HINDZINC's 77% domestic market share and proximity to its existing smelting operations. By fostering a downstream ecosystem, the company aims to drive value addition and sustainable metal processing.
Key Highlights
Partnership with CMR Green Technologies, India's largest non-ferrous metal recycler.
Focus on high-quality zinc alloys for automotive, infrastructure, and consumer goods.
Recycled metal production at the facility can achieve up to 95% lower emissions.
Hindustan Zinc maintains a dominant 77% share of India's primary zinc market.
Zinc Park is developed jointly with RIICO as a renewable energy-powered industrial hub.
💼 Action for Investors
This expansion into downstream value-added products is a positive long-term driver for margins and market positioning. Investors should monitor the scaling of Zinc Park as a catalyst for industrial demand.
Polycab Receives Rectification Order; Income Tax Demand Reduced to ₹57.58 Cr from ₹327.45 Cr
Polycab India has successfully contested an initial income tax demand for the Assessment Year 2024-25, resulting in a significant reduction of the liability. The Income Tax Authority issued a rectification order reducing the demand from ₹327.45 crore to ₹57.58 crore after correcting clerical and computational errors. The company maintains that the remaining ₹57.58 crore demand is still incorrect due to uncredited advance taxes and plans to file further rectifications. Additionally, Polycab will appeal the underlying additions of ₹41.87 crore, asserting that the demand is not legally sustainable.
Key Highlights
Income tax demand reduced by approximately 82% from ₹327.45 crore to ₹57.58 crore.
The reduction follows a rectification application filed under Section 154 of the Income Tax Act.
Remaining demand of ₹57.58 crore is attributed to non-granting of advance tax credits.
Original additions and disallowances leading to the dispute aggregate to ₹41.87 crore.
Company is in the process of filing an appeal against the additions, citing they are not sustainable in law.
💼 Action for Investors
Investors should view this as a positive development as it significantly reduces a potential financial liability. Monitor the outcome of the subsequent rectification and the legal appeal regarding the core additions.
Delta Corp to Hold EGM on April 9 for Shipbuilding Contract and Corporate Guarantee Approval
Delta Corp has scheduled an Extra-ordinary General Meeting (EGM) for April 9, 2026, to seek shareholder approval for two key financial matters. The board is proposing modifications to a shipbuilding contract between its wholly-owned subsidiary DPCCPL and associate company WSPL. Additionally, approval is sought for a corporate guarantee to be provided by subsidiary DPCCL for a loan proposed to be taken by WSPL. These moves indicate continued financial support and capital commitment toward its associate entities.
Key Highlights
Extra-ordinary General Meeting (EGM) scheduled for April 9, 2026, via Video Conferencing.
Modification of shipbuilding contract between subsidiary DPCCPL and associate company WSPL.
Proposed corporate guarantee by subsidiary DPCCL for a loan to be availed by associate WSPL.
Board meeting concluded at 6:15 P.M. on March 10, 2026, following a 45-minute session.
💼 Action for Investors
Investors should review the detailed EGM notice when released to understand the financial scale of the loan guarantee and contract modifications. Monitor the impact of these contingent liabilities on the company's consolidated balance sheet.
Aditya Birla Capital Allots NCDs Worth Rs 755 Crore via Private Placement
Aditya Birla Capital has successfully allotted Non-Convertible Debentures (NCDs) totaling Rs 755 crore across three distinct tranches on March 10, 2026. The fundraise includes a major tranche of Rs 430 crore at a 7.10% coupon rate maturing in 2031 and Rs 300 crore at 7.2959% maturing in 2028. These securities are secured, rated, and will be listed on both BSE and NSE. This capital infusion is part of the company's routine financing strategy to support its lending and financial services operations.
Key Highlights
Total allotment of 34,550 Non-Convertible Debentures aggregating to Rs 755 crore.
Tranche 1: Rs 300 crore at 7.2959% coupon rate with maturity on September 15, 2028.
Tranche 2: Rs 25 crore at 9.1500% coupon rate with maturity on December 21, 2028.
Tranche 3: Rs 430 crore at 7.1000% coupon rate with maturity on October 3, 2031.
NCDs are secured by a first pari passu charge over receivables, securities, and other identified assets.
💼 Action for Investors
This is a routine fundraise for a financial services firm and indicates healthy access to credit markets. Investors should continue to monitor the company's net interest margins and overall debt-to-equity levels.